EUCAN-Connect (2019–2023) explicitly tasked EPIGENY with building a federated FAIR platform enabling large-scale analysis of cohort data across Europe and Canada.
EPIGENY
French health data SME building federated platforms for cross-border epidemiological cohort analysis and patient data harmonization.
Their core work
EPIGENY is a Paris-based health data SME specializing in the infrastructure and governance needed to connect large-scale epidemiological cohort datasets across borders. Their core work involves building federated data platforms that allow researchers to analyze patient cohort data without centralizing sensitive records — preserving privacy while enabling meaningful scientific collaboration. In practice, this means data curation, harmonization of heterogeneous cohort datasets, and technical integration of research databases spanning multiple countries and funding bodies. They operate at the precise intersection of computational biology, health informatics, and data governance — making them a rare private-sector actor in a space dominated by academic institutions and public research institutes.
What they specialise in
Both SYNCHROS and EUCAN-Connect address harmonization of prospective cohort data, with SYNCHROS specifically focused on integrating cohort roles across multiple stakeholder groups and funding bodies.
SYNCHROS (2019–2022) is explicitly an epidemiology-focused project; EUCAN-Connect also centers on prospective cohort studies, placing epidemiological data at the core of EPIGENY's work.
EUCAN-Connect keywords include both 'data curation' and 'privacy,' indicating EPIGENY contributes to the governance and compliance layer of cross-border data sharing.
EUCAN-Connect cites computational biology and biotechnology among its technical domains, suggesting EPIGENY brings analytical and biological interpretation capabilities alongside pure data engineering.
How they've shifted over time
Both H2020 projects began in 2019, so the evolution between them reflects a thematic shift rather than a long timeline arc. In EUCAN-Connect — their larger, longer project — the focus was squarely on the technical infrastructure: computational biology methods, data curation pipelines, privacy-preserving architecture, and the EU-Canada data bridge. In SYNCHROS, the emphasis moves downstream toward the people and processes: patients, clinical trials, funding bodies, and the harmonization of roles across the research ecosystem. This suggests EPIGENY is maturing from pure platform-building toward a broader understanding of how cohort data platforms must serve clinical and governance realities, not just technical ones.
EPIGENY appears to be moving from infrastructure-layer technical work toward applied cohort research governance — a trajectory that would make them increasingly relevant for clinical trial data management, real-world evidence platforms, and multi-country patient registry projects.
How they like to work
EPIGENY has participated only as a consortium partner — never as coordinator — across both projects, suggesting they enter consortia as a focused technical or methodological contributor rather than as a project driver. Despite their small size and limited project count, they have accumulated 27 unique partners across 13 countries, which is unusually broad for a two-project SME and implies they are embedded in large, well-networked EU health research consortia. Working with EPIGENY likely means engaging a specialized, agile private actor who brings specific data platform expertise to a larger academic-led effort.
EPIGENY has collaborated with 27 distinct partners across 13 countries despite only two projects — indicating participation in large, internationally distributed consortia. The explicit EU-Canada dimension of EUCAN-Connect gives their network a transatlantic reach uncommon among French health SMEs of this size.
What sets them apart
EPIGENY occupies a narrow but high-value niche: a private SME that operates inside the academic health data infrastructure world, contributing commercial agility and applied data engineering to consortia that are otherwise dominated by universities and research institutes. Their combination of computational biology knowledge, privacy-aware data architecture, and cohort harmonization methodology is difficult to replicate in a single organization, particularly at SME scale. For a consortium needing a partner who bridges the gap between research informatics and real-world clinical data governance, EPIGENY offers a credible, specialized profile without the overhead of a large institution.
Highlights from their portfolio
- EUCAN-ConnectThe largest of their two projects (EUR 366,250; running until 2023), it is also the most technically ambitious — a federated FAIR data platform spanning Europe and Canada, representing EPIGENY's clearest demonstration of cross-border health data infrastructure capability.
- SYNCHROSA coordination and support action (CSA) rather than a research project, SYNCHROS shows EPIGENY's ability to contribute to policy-adjacent, multi-stakeholder cohort governance work — a different register from pure technical platform development.